You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國務院剛確定了常用藥保供穩價措施李克強今天就來到哈藥集團生物工程有限公司
格隆匯 08-20 14:50
格隆匯8月20日丨李克強8月20日來到哈藥集團生物工程有限公司,瞭解企業藥品價格、生產研發以及減税降費是否到位等情況。在製劑車間,總理仔細察看藥品生產工藝和流程。4天前,總理主持召開國務院常務會議,確定加強常用藥供應保障和穩定價格的措施,確保羣眾用藥需求和減輕負擔。此次來到哈藥集團,李克強實地調查瞭解影響常用藥供應和價格的各個環節。總理説,藥品屬於特殊商品,製藥企業既要實現良好經營,也要承擔一定的社會責任,保障基本藥物等常用藥正常供應。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account